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EDITORIAL
What’s up in abdominal radiology?
Wolfgang Schima
Department of Radiology, University of Vienna, Austria
The advent of multi-detector array CT (MDCT) has
turned many things in abdominal radiology upside down.
MDCT is a technique with great possibilities for several
specific applications in the abdomen.
For example, the results of many well-performed
clinical studies on MDCT colonography for polyp
detection were presented at the ECR in Vienna and at
the joint meeting of the ESGAR and SGR in Orlando.
MDCT colonography achieves excellent sensitivity for
the detection of polyps as small as 5 mm, but is still
not reliable for the visualization of smaller polyps. Thus,
the debate continues about how to proceed in patients
with tiny polyps found or suspected at CT colonography.
The risk of malignant transformation of such tiny polyps
is virtually zero and it is probably reasonable to simply
follow these patients.
The amount of ionizing radiation, which has been
cited as a barrier to the use of MDCT as a colorectal
cancer-screening tool, can be vastly reduced. A low dose
technique, with noise-reduction algorithm using edge-
preserving, yields comparable results, and it brings the
amount of radiation delivered during a CT colonography
scan into the range of a few chest X-rays. This may open
the potential for the use of MDCT in screening, similar to
current screening for lung cancer.
For pancreatic imaging the pendulum swings toward
CT. The exquisite 3D-display of tumors and their relation
to the vasculature is of real benefit to pancreatic surgeons.
In several centers, studies have begun to examine pre-
operative chemotherapy for locally inoperable pancreatic
cancer. With MDCT alone, it is not possible to assess
treatment response accurately, but the combination of
PET/CT to assess the biological activity of tumors
is a method that offers promise for every oncologic
radiologist.
Is there still a role for MRI in abdominal radiology?
Oh, yes. MRI has matured into a widely accepted
technique for liver imaging. There are several MR
contrast agents for liver imaging that can optimize studies
for every indication. Even the registration of second-
generation ultrasound contrast agents in the European
Union is not likely to win against MRI and MDCT.
Another example is dynamic MR imaging of the small
bowel, which has indeed recovered ground from CT
and barium radiography for imaging of patients with
small bowel obstruction. So the days of ‘old-fashioned’
enteroclysis seem to be numbered. Functional MRI is
the first imaging modality ever to show intra-abdominal
adhesions reliably, and small bowel MRI can delineate all
tumors.
So there is life after MDCT. Since the EURATOM
directive 97/43 took effect, the radiology community
is committed to reducing radiation exposure to the
population. More than ever, we are now asked to choose
the most effective and least invasive imaging technique
from a whole range of imaging modalities we have at our
fingertips.
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